Brasofensine is a monoamine reuptake blocker is a phenyltropane that had been under development for the treatment of Parkinson's and Alzheimer's disease. In animal models of Parkinson's disease, brasofensine was effective in stimulating LMA and reversing akinesia. The (Z)-isomer has been consigned the name BMS-205912. References: Frackiewicz EJ, Jhee SS, Shiovitz TM, Webster J, Topham C, Dockens RC, Whigan D, Salazar DE, Cutler NR. Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa. Ann Pharmacother. 2002 Feb;36(2):225-30. PubMed PMID: 11847938.

纯度：≥98%

CAS：171655-91-7